Tumor-derived CCL2 drives tumor growth and immunosuppression in IDH1- mutant cholangiocarcinoma.
肿瘤来源的 CCL2 驱动 IDH1 突变型胆管癌的肿瘤生长和免疫抑制
期刊:Hepatology
影响因子:15.8
doi:10.1097/HEP.0000000000001185
Zabransky Daniel J, Kartalia Emma, Lee Jae W, Leatherman James M, Charmsaz Soren, Young Sara E, Chhabra Yash, Franch-Expósito SebastiÃ, Kang Martin, Maru Saumya, Rastkari Noushin, Davis Michael, Dalton William Brian, Oshima Kiyoko, Baretti Marina, Azad Nilofer S, Jaffee Elizabeth M, Yarchoan Mark
